Companies Contributing Pet Pharmaceuticals Market to Achieve 7.0% CAGR from 2021 to 2026

The global Pet Pharmaceuticals market was valued at US$ 13400 million in 2020 and is expected to reach US$ 21470 million by the end of 2027, growing at a CAGR of 7.0% during 2021-2027.

Pet pharmaceutical refers specifically to medicines given to pets.

In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved.

In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.

North America is the largest production and consumption region market with about 49% revenue market share in 2019.

The key players are Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Chopperlvya Animal Health, CAHIC etc. Zoetis is leader company with about 36% revenue market share in 2019.

Global Pet Pharmaceuticals Market: Drivers and Restrains

The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.

Global Pet Pharmaceuticals Market: Segment Analysis

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.

Key Companies profiled in this report are Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Chopperlvya Animal Health, CAH and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.

Find more details at:

Segment by Type

  • Antiparasitic
  • Biological Products
  • Antibacterial
  • Others

Segment by Application

  • Prevention
  • Treatment

Table of Content:

1 Pet Pharmaceuticals Market Overview

2 Pet Pharmaceuticals Market Competition by Manufacturers

3 Pet Pharmaceuticals Retrospective Market Scenario by Region

4 Global Pet Pharmaceuticals Historic Market Analysis by Type

5 Global Pet Pharmaceuticals Historic Market Analysis by Application

6 Key Companies Profiled

7 Pet Pharmaceuticals Manufacturing Cost Analysis

8 Marketing Channel, Distributors and Customers

9 Pet Pharmaceuticals Market Dynamics

10 Global Market Forecast

11 Research Finding and Conclusion

12 Methodology and Data Source

Media Contact

Company Name: The Market Reports

Contact Person: Shirish Gupta


Phone: +1-631-407-1315

Leave a Reply

Your email address will not be published. Required fields are marked *